Kura Oncology, Inc. (KURA) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,130
Total Return
-68.70%
CAGR
-20.73%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.55% |
| Median | -2.80% |
| Best | +58.84% |
| Worst | -47.82% |
| % of Windows Positive | 42.5% |
1-Year (252 Trading Days)
| Average | -4.04% |
| Median | -19.77% |
| Best | +132.78% |
| Worst | -75.12% |
| % of Windows Positive | 36.9% |
3-Year (756 Trading Days)
| Average | -29.26% |
| Median | -31.32% |
| Best | +28.02% |
| Worst | -69.18% |
| % of Windows Positive | 13.2% |
Risk Metrics
| Maximum Drawdown | -81.20% |
| Average Drawdown | -53.22% |
| Drawdown Duration | 1253 Trading Days (Unrecovered) |
| Sortino Ratio | -0.11 |
| Calmar Ratio | -0.26 |
| CVaR (5%) | -7.64% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -12.03% (-36.25% ann.) | $1203.09 | $0.00 | $0.00 | $0.00 |
| 2025 | +19.29% | +$1928.82 | $0.00 | $0.00 | $0.00 |
| 2024 | -39.43% | $3942.97 | $0.00 | $0.00 | $0.00 |
| 2023 | +15.87% | +$1587.44 | $0.00 | $0.00 | $0.00 |
| 2022 | -11.36% | $1135.71 | $0.00 | $0.00 | $0.00 |
| 2021 | -57.13% | $5713.41 | $0.00 | $0.00 | $0.00 |
| 2020 | +137.53% | +$13752.71 | $0.00 | $0.00 | $0.00 |
| 2019 | -2.07% | $206.55 | $0.00 | $0.00 | $0.00 |
| 2018 | -8.24% | $823.53 | $0.00 | $0.00 | $0.00 |
| 2017 | +159.32% | +$15932.23 | $0.00 | $0.00 | $0.00 |
| 2016 | -29.76% | $2976.20 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -44.00% (-86.44% ann.) | $4400.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 16, 2015 – February 19, 2020 | -18.87% | -4.61% | $1886.67 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -36.30% | -99.42% | $3629.76 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +306.83% | +856.22% | +$30682.59 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -63.09% | -61.16% | $6309.24 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -3.30% | -3.50% | $329.52 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +32.37% | +16.33% | +$3237.04 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -54.89% | -39.79% | $5488.65 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.